22168-07-6Relevant articles and documents
ARYLAMIDES AND METHODS OF USE THEREOF
-
Page/Page column 108, (2021/06/11)
The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
Pharmaceutical compounds
-
Page/Page column 9, (2008/06/13)
Tricyclic pyrazole derivatives of the following formula (I) having affinity for the cannabinoidergic CB1 and/or CB2 receptors: wherein: A represents a group selected from one of the following: (CH2)t—, —(CH2)—S(O)z/s